Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Healthcare Ishares ETF (IYH)

US Healthcare Ishares ETF (IYH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 2,633,358,000
  • Shares Outstanding, K 9,800
  • 60-Month Beta 0.77
Trade IYH with:
  • Price/Earnings ttm 29.99
  • Annual Dividend & Yield 3.44 (1.28%)
  • Most Recent Dividend 0.530 on 06/10/21
  • Management Fee 0.43%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 12.44%
  • Historical Volatility 10.83%
  • IV Percentile 4%
  • IV Rank 24.40%
  • IV High 30.77% on 10/30/20
  • IV Low 6.52% on 04/19/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 1.22
  • Today's Open Interest 60
  • Open Int (30-Day) 60

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.11 +3.51%
on 06/03/21
270.92 -0.62%
on 06/10/21
+4.38 (+1.65%)
since 05/14/21
3-Month
244.65 +10.05%
on 03/25/21
270.92 -0.62%
on 06/10/21
+18.53 (+7.39%)
since 03/16/21
52-Week
208.96 +28.85%
on 06/25/20
270.92 -0.62%
on 06/10/21
+54.73 (+25.51%)
since 06/16/20

Most Recent Stories

More News
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results

Johnson & Johnson (JNJ) continued its long streak of earnings beat and outpaced revenue estimates. However, the company tightened its full-year guidance.

JNJ : 164.96 (+0.29%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHE : 187.94 (+0.54%)
IEIH : 34.62 (+0.55%)
Healthcare ETFs to Gain on UnitedHealth's Strong Q1 Earnings

UnitedHealth Group (UNH) reported better-than-expected first-quarter 2021 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full-year earnings...

UNH : 400.08 (-0.05%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHF : 264.78 (+0.04%)
IEHS : 40.78 (+0.23%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 164.96 (+0.29%)
XLV : 124.89 (+0.15%)
IYH : 269.24 (+0.22%)
IHE : 187.94 (+0.54%)
FTXH : 26.14 (+0.25%)
IEIH : 34.62 (+0.55%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 164.96 (+0.29%)
XLV : 124.89 (+0.15%)
IYH : 269.24 (+0.22%)
IHE : 187.94 (+0.54%)
FTXH : 26.14 (+0.25%)
IEIH : 34.62 (+0.55%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 164.96 (+0.29%)
PFE : 39.61 (+0.05%)
MRNA : 197.51 (-2.02%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHE : 187.94 (+0.54%)
IEIH : 34.62 (+0.55%)
Healthcare ETFs in Focus on UnitedHealth's Solid Q4 Earnings

UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.

UNH : 400.08 (-0.05%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHF : 264.78 (+0.04%)
IEHS : 40.78 (+0.23%)
ETFs to Gain on UnitedHealth and Change Healthcare Deal

UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.

UNH : 400.08 (-0.05%)
MGLN : 94.26 (+0.02%)
CNC : 73.71 (+5.30%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHF : 264.78 (+0.04%)
IEHS : 40.78 (+0.23%)
CHNG : 23.26 (-0.51%)
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

JNJ : 164.96 (+0.29%)
PFE : 39.61 (+0.05%)
GILD : 68.54 (+0.66%)
MRK : 77.10 (+1.85%)
LLY : 221.91 (-0.72%)
BMY : 67.38 (-0.06%)
AMGN : 242.06 (+0.92%)
ABBV : 115.94 (+0.09%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
FHLC : 62.87 (+0.15%)
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

JNJ : 164.96 (+0.29%)
PFE : 39.61 (+0.05%)
GILD : 68.54 (+0.66%)
MRK : 77.10 (+1.85%)
LLY : 221.91 (-0.72%)
BMY : 67.38 (-0.06%)
AMGN : 242.06 (+0.92%)
ABBV : 115.94 (+0.09%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
FHLC : 62.87 (+0.15%)
UnitedHealth Q3 Solid Result Put Healthcare ETFs in Focus

UnitedHealth reported better-than-expected third-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full year outlook.

UNH : 400.08 (-0.05%)
XLV : 124.89 (+0.15%)
VHT : 243.64 (+0.07%)
IYH : 269.24 (+0.22%)
IHF : 264.78 (+0.04%)
IEHS : 40.78 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The iShares U.S. Healthcare ETF seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The Fund seeks investment results that correspond to the performance of the Dow Jones U.S. Health Care Index. The Fund will concentrate its investments in the healthcare...

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 270.87
2nd Resistance Point 270.12
1st Resistance Point 269.39
Last Price 269.24
1st Support Level 267.91
2nd Support Level 267.16
3rd Support Level 266.43

See More

52-Week High 270.92
Last Price 269.24
Fibonacci 61.8% 247.25
Fibonacci 50% 239.94
Fibonacci 38.2% 232.63
52-Week Low 208.96

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar